15-16 April 2025
Mövenpick Grand Al Bustan – Dubai, UAE
The GCC Quality Conference, is focused on the Commercial Quality Perspective and is the First Gathering Point for Commercial Quality Professionals in the GCC.
Regardless of the business, quality, is one of the most crucial management concepts for every firm.
This is especially true for the pharmaceutical industry, where upholding high product standards is crucial for the treatment and prevention of a wide range of diseases.
Overall, the GCC Quality Conference aims to foster a culture of quality excellence in the GCC region’s commercial sector.
Despite the fact that the pharmaceutical business has been operating for millennia, more pharmaceuticals have recently been introduced to the market. The demand for quality assurance and quality control procedures in the commercial state has increased as a result of this development.
Pharma QA and quality assurance departments are the backbones of the pharmaceutical business. They allow companies to guarantee that their products conform to applicable quality, drug stability and safety standards. In addition, they ensure that a company avoids non-compliance of regulatory requirements
Where
Movenpick Grand Al Bustan – Dubai, UAE
When
15-16 April 2025
SPEAKERS
150+ Speakers
SEATS
100+ Seats
Gold Sponsor AbbVie:
Mr. Amjad Matouk
Gold Sponsor – Takeda Pharmaceuticals:
Dr. Rasha Elbohi
Silver Sponsor – Bayer:
Dr. Hazem Asad
The GCC Quality Conference, which is the first meeting place for commercial quality professionals in the GCC, will be focused this year on the commercial quality perspective.
the GCC Quality Conference is specifically focusing on the commercial quality perspective. This means that the discussions, presentations, workshops, and panel sessions at the conference will center around various aspects of quality management within the commercial sector.
Commercial quality encompasses the processes, systems, and practices implemented by businesses to ensure that their products or services meet or exceed customer expectations and industry standards.
Individuals and organizations can enhance their understanding of quality requirements, procedures, and best practices, ultimately leading to improved quality outcomes and organizational success in the pharmaceutical sector.
Speakers 2024
The GCC Regulatory Affairs Pharma Summit 2025 gathers experts to explore regulatory updates, compliance, and pharma innovations in the Gulf.
MR. MOHAMED HAYANI
Mohamed Hayani Quality Assurance Manager handling the MENA region at NewBridge, has over 20 years of experience within the pharmaceuticals industry manufacturing facilities and commercial operations.
Quality Assurance professional with progressive experience with market-leading multinationals in pharmaceutical worked with senior leadership teams at regional on strategic initiatives aimed to grow and reshape businesses, I have successfully increased efficiency and productivity while reducing cost.
Mohamed Hayani is a holder of a bachelor’s degree in Applied Chemistry from Aleppo University, and holder of a CMQ certificate at ASQ (American Society for Quality).
DR. NAHED YAISH
- 20 experience in Pharma Industry
- 15 years experience as Qualified Person Responsible for Pharmacovigilance/Local Safety Responsible, Quality Assurance Responsible Person
- 5 years experience as Consultant for RA- Business Development, Pharmacovigilance & QMS
- Qualified International Trainer by International College in London
- Owner & Founder of State Of Practices Consultancy Center
MS. JULIE ZINGARELLI
Julie Zingarelli is a biomedical engineer with 9 years of experience in quality systems and compliance bringing a unique blend of industry expertise dealing with FMCGs and Pharmaceuticals in Switzerland.
She currently provides consultancy services focused on Inspection Readiness, including data governance and provides coaching prior to any virtual, hybrid or on-site audit.
MS. MONA ELHAWARY
Mona is the Senior Quality Manager at Haleon responsible for Gulf, Near East & Saudi Arabia. She is the Risk Management lead in Middle East Africa and subject matter expert for Deviation, Investigation, RCA and CAPA.
Before this, she held the role of Quality Head in Merck responsible for Egypt and Africa Developing Markets.
She has also been appointment to multiple roles as QMS champion, Data Integrity lead as well as Validation & CSV lead
In addition to this, Mona is a Lead Quality auditor, pharmaceutical sites’ due diligence and inspection readiness expert
Education & Certificates:
Bachelor of Pharmaceutical Sciences – Cairo University, Egypt
Certified Quality Manager – American Society for Quality (ASQ)
MR. MAZEN BOUGHANEM
Ingenious Quality Leader with over 23 years of profound GxP experience in sterile/nonsterile pharmaceutical and medical device within the context of Technical Ops, Manufacturing, CMO, Distribution and Commercial operations including over 12 years in a leadership position in multinational business culture. His experience spans across North America, EMEA and China.
He had a track record of leveraging multidisciplinary teamwork to establish and sustain a fit for purpose risk based QMS in accordance with USFDA, EU, Health Canada, and GCC regulations for sites globally. He was keen on fostering a culture of Data Integrity compliance and achieving corporate compliance governance which resulted in outstanding regulators inspection outcomes.
At a Global role, Mr. Mazen played a pivotal role in driving various business initiatives such as Pharma 4.0 and governance compliance programs, leveraging his strengths in risk-based critical thinking, problem-solving, and proactive process control.
His leadership has led to quality transformations and seamless integration of new acquisitions worldwide, showcasing his precision and efficiency in executing strategic initiatives. Further, he deployed operational excellence utilizing lean manufacturing principles and kaizen tools, which optimized processes, reduced product defects, and positively impacted the bottom line, while upholding stringent quality standards.
A hallmark of Mr. Mazen’s career is his distinctive collaborative leadership style, forward-thinking mindset, integrity, unwavering commitment to continuous improvement and recognition as a change agent characterized by agility and resilience. These attributes have established him as a respected professional in the industry.
MS. SALMA KHALIFA
Salma Khalifa is a pharmacy and biotechnology bachelor’s degree holder with a Post-graduate Diploma in Total Quality Management & Six Sigma certification. She has extensive experience of 12 years in the development and implementation of Quality Management Systems, including compliance, auditing, dealing with Health Authorities, and leading quality governance end to end across the full chain from design until reaching patients. Sara’s experience also includes driving global projects, implementing changes across the organization, leadership, and operational excellence.
MR. FABRIZIO MANIGLIO
Fabrizio Maniglio is an industry thought leader and the Director of Industry and Business Development for Honeywell. He leverages vast subject matter expertise to drive innovation for the industry and within Honeywell, where he continuously monitors the evolution of the ever-changing healthcare and life-sciences sectors. He fosters contacts with other industry thought leaders and regulators to collaborate and influence the future of our industry.
He contributed five years as an Expert Solutions Engineer with Honeywell – Sparta Systems, deepening his understanding of quality life cycle management and the life science industries. He was a key differentiator in helping customers achieve their quality management goals.
Before Sparta Systems, he served nine years at a leading European-based Contract Manufacturing Organization (CMO) in the Pharma, Biotech, and Specialty ingredients industry. He served in numerous global quality-related roles, spanning Deviations Management, Head of Audit QA and Compliance, and most recently as QA Manager for Data Integrity and Computer Systems Validation in Switzerland, the UK, and China.
As a result, Fabrizio provides a blend of deep industry, QMS, and cutting-edge technical knowledge and is uniquely placed to advise customers and the industry on the future of quality.
MR. AHMED YOUSRY ABOUZEID
With over 15 years of experience in life science production, quality assurance, and supply chain operations, he is a seasoned professional who strives for continuous improvement and excellence in his field.
He is responsible for establishing and leading the quality management framework and system for the cluster, covering 64 countries in the Middle East and Africa region.
He works closely with the EMEA Senior Director and the regional teams to ensure compliance with local and global regulations, as well as to mitigate potential or actual non-compliance risks. His mission is to enable and facilitate world-class operational and customer-focused capabilities while fostering a culture of innovation and collaboration.
DR. RACHEL RIZKALLAH
Experienced Pharmacist in Quality Assurance with 9+ years’ experience in the pharmaceutical industry. Skilled in Quality Management Systems, Documentation Management, training and GxP implementation. Passionate about Quality Assurance and implementation of GDP across the supply chain and warehouses through auditing and mentoring. Holder of a pharmaceutical Doctorate from Lebanese American University following clinical rotations at the Methodist Hospital Houston. Currently working as Quality Assurance Manager covering Gulf and Levant at AbbVie Biopharmaceuticals GmbH.
MR. ADEL NASR ABD EL WAHAD
He is an experienced professional in the pharmaceutical industry, with more than 23 years of experience within different functions and countries. serving as a Distribution and Commercial Relations Manager in Bayer. With a keen understanding of market dynamics and a knack for building strong relationships with distributors, he excels in establishing the distribution management model for Bayer pharma in the ME and building strategic partnership to pave the way for Bayer access in GCC, Levant and Egypt through different go to market models.
MR. ROBERT HANLON
Head of Quality Compliance, Audit and Technical Projects for Aspen Pharma covering Europe and Middle East.
A quality leader with a wealth of experience garnered from both industry and working with a national competent authority (HPRA, Ireland).
A diverse 18-year career within the pharmaceutical industry across R&D, Quality Control, Quality Assurance, Compliance and Technical Affairs covering sterile and non-sterile products. Leveraging an in-depth understanding of global regulatory requirements to apply a unique insight into the intricacies of compliance.
Successfully managed numerous multi-million-dollar technology transfer projects internationally.
Has a passion for mentoring and building a quality culture that stands the test of time while working towards the primary goal of ensuring product safety, efficacy, and quality.
DR. RADWA ABD ELAH SAYED
Dr. Radwa Abd Ellah Sayed is a highly accomplished professional with a distinguished career in quality assurance and regulatory affairs within the Egyptian Drug Authority. Her dedication to quality and expertise in regulatory systems have been instrumental in both national and international advancements. Currently, Dr. Radwa serves as a Senior Quality Assurance Specialist within the General Administration of Quality Assurance at the EDA.
Qualifications
Master’s degree in Biochemistry from the Faculty of Science at Cairo University in 2019, where the thesis focused on evaluating the effectiveness of vaccines containing tetanus
Bachelor’s degree in Chemistry and Biochemistry from the Faculty of Science in
Certificates and Training
Diploma in Total Quality Management from Brooklyn
Certified Project Management Professional (PMP) from the Project Management Institute (PMI).
Completed numerous trainings and workshops in various fields of the
Career Highlights:
Joined the National Organization for Research and Control of Biologicals in
Progressed in the National Organization for Research and Control of Biologicals in the Lot Release
Qualified for the position of Deputy Manager of the Lot Release Department in
Joined the Technical Office of the Central Administration for Biologicals, Clinical Studies, and Innovative Products from February 2019 to September
Qualified for the position of Manager of the Vaccines and Sera Lot Release Unit in
Assigned tasks as Quality Supervisor for Lot Release Management, in addition to her role as Manager of the Vaccines and Sera Release Unit in
In 2022, joined the General Administration of Quality Assurance as a Document Control Officer, then as a Risk Management Officer in 2023.
Assigned various other tasks within the administration such as Coordinator for the Institutional Excellence Award from the General Quality Management and Performance Indicators Monitor for the authority, and Coordinator for the Media office.
Contributions to Quality and Regulatory Systems and the achievements:
Contributed to the preparation of the Lot Release risk-based
Prepared all work procedures for Lot Release administration according to the new
Speaker at the first workshop held by the Egyptian Drug Authority in 2021 on Lot Release
Speaker at a workshop for Lot Release administration held by the Egyptian Drug Authority for companies on Product Quality Review (PQR).</h5>
Member of the WHO GBT for vaccines (Lot release function) task force as Unit Manager and Quality
Contributed to the preparation of the Egyptian Drug Policy and coordinated between various stakeholders and prepared the draft presented to the World Health
Member of the WHO GBT for pharmaceuticals (Regulatory system function) task
Member of the RCORE team on the Regulatory
Member of governance committees and monitoring committees for corrective actions within the
Prepared a file to qualify for the Best Team Award in one of the categories of the Egyptian Drug Authority’s competition in 2023 under the supervision of the General Manager of the General Administration of Quality Assurance and obtained first place in this
Member of the training team in the training program of the Yemeni High Authority for Medical Supplies on the topic:
Data Integrity and Good Documentation Practice: The Foundation of
Speaker at workshops and training sessions for General Quality Management to spread quality culture and increase awareness of the quality system in various topics:
QMS Documentation and Document Control: The Foundation of
Navigating Uncertainty: Effective Risk Management
Driving Success: Navigating Key Performance Indicators for Optimal
Awards and Honors:
Certificate of appreciation for dedicated efforts in achieving WHO GBT (Level 3 maturity) accreditation for vaccines in 2022.
The General Quality Assurance Management team won first place in the Best Team category in the Excellence Award competition from the Egyptian Drug Authority for
EDA HEROS Employee Excellence Award for their outstanding efforts, remarkable contributions, and positive impact in 2023.
Certificate of appreciation for tremendous efforts in implementing the new Integrated Quality Management System in 2023.
MR. AMJAD MATOUK
Amjad Matouk heads the Commercial Quality Assurance function for Middle East and North-West Africa at AbbVie. He has over 17 years of validation and quality leadership experience within the pharmaceuticals industry spanning manufacturing facilities and commercial operations.
A Quality leader who played critical role in setting up QA systems and processes at several organization balancing between Quality needs and commercial priorities. Moreover, He has helped develop processes unique to the MENA region helping support business and quality needs.
In the validation field, he has ranging experiences that include cleaning, mixing/batching, equipment installation, and sterilization. He led a project that was instrumental in reducing water consumption for the rising process by over 40%.
Amjad is a holder of a bachelor’s in chemical engineering from The University of Texas at Austin and an MBA holder from Texas A & M University – Kingsville.
DR. MAHMOUD ELGHANDOUR
Dr. Mahmoud is working in MOHAP, drug department since 2020, with a master degree in pharmaceutical analytical chemistry, he is a technical affairs and regulatory specialist at MOHAP, with 16 years of experience in the management and advisory on quality system for leading companies within pharmaceutical manufacturing field.
Before joining MOHAP, Mahmoud was quality control manager in Julphar, RAK and Adcan pharma, Abu Dhabi
Dr. Mahmoud has many published research in the USA AOAC journal about evaluation of pharmaceutical dosage forms in human biological fluids and stability studies.
DR. AYMAN ISMAIL
Dr. Ayman is a Regional LOC Quality Executive at Haleon for Gulf, Near East & KSA with former experience in North Africa, French West Africa, and Southern Africa in addition to being a Subject matter expert in Analytical science and technology for MEA region. Dr. Ayman is a Lead internal and external quality auditor in addition to being an Experienced Technical Services and Stability section head with a demonstrated history of working in the pharmaceuticals industry, Pharmaceutics, Statistical Data Analysis, Lean Six Sigma. In addition, Dr. Ayman is a master’s degree holder in Drug technology and Pharmaceutics from Ain Shams University, Egypt.
Education & Certificates:
Bachelor of Pharmaceutical Sciences – Ain Shams University, Egypt
Masters in Drug Technology & Pharmaceutics – Ain Shams University, Egypt
Certified Black Belt Six Sigma – American Society for Quality (ASQ)
Certified Quality Auditor – American Society for Quality (ASQ)
Research & Publications
Optimization of Analytical Method for Simultaneous Determination of Acetaminophen, Caffeine, and Aspirin in Tablet Dosage Form
Pharmaceutical Chemistry Journal · Mar 18, 2023
Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
International Journal of pharmaceutics · May 1, 2020
DR. RASHA ELBOHI
Rasha Elbohi has 14 years of experience within the pharmaceutical industry in regulatory Affairs across 3 regions Middle East, Egypt & Algeria. Rasha is currently the Middle East region Quality Lead in Takeda.
Before joining Takeda Pharmaceuticals company, Rasha was Operational Quality Manager of GlaxoSmithKline Cairo site among other Quality roles for 8 years before joining Takeda.
Prior to GSK, Rasha worked for EVA pharmaceuticals for 3 years and as a Biotechnology and Immunology Teaching assistant at the German University in Cairo shortly after graduating GUC with a bachelor’s in pharmacy and biotechnology in 2010. Additionally, Rasha holds a Diploma in Total Quality Management from the American university in Cairo.
DR. HAZEM ASAD
Hazem has over 20 years of experience in Pharmaceutical Quality and Commercial Operations. He has 15 years of experience in senior positions at multinational companies building up and implementing integrated Quality Management Systems in several organisations and leading practical organisational change towards quality orientations, innovation, and digitalization.
Attending the GCC Quality Conference offers numerous advantages for professionals in the pharmaceutical industry. By participating in this conference, you will:
- Gain a broad understanding of quality measures
- Stay informed about quality procedures and updates from industry & governmental speakers
- Network with industry & GCC governmental professionals & share your expertise
Overall, attending the GCC Quality Conference in the pharmaceutical industry allows you to enhance your understanding of quality measures, stay updated with procedures and regulations, expand your professional network, and contribute to the industry’s knowledge sharing.
The GCC Quality Conference provides a valuable opportunity for individuals and organizations to enhance their understanding of the requirements and procedures necessary to effectively process and manage the quality department within their organization. Specifically, the conference aims to focus on the pharmaceutical industry and how organizations can excel in terms of quality management.
By attending the GCC Quality Conference, participants can expect to gain insights into various aspects of quality management in the pharmaceutical sector. This includes understanding the regulatory requirements and standards specific to the industry, as well as the best practices and strategies employed by successful organizations.